Skip to content

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06406972
Enrollment
1343
Registered
2024-05-09
Start date
2010-09-15
Completion date
2026-04-01
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder, Emergency Psychiatric, Hospitalizations Psychiatric, Self-harm, Self-injury, Suicide, Suicide, Attempted

Keywords

Brief Admission by self-referral, self-harm, traits of borderline personality disorder, compulsory care

Brief summary

Brief Admission by self-referral (BA) is a standardized treatment model, providing patient-controlled and person-centered care. It was developed to reduce self-harm and compulsory care by promoting autonomy. Randomized clinical trials have not yielded significant between group differences with respect to inpatient care, including compulsory care. The major difficulty in evaluating BA is preventing the control group from cross-contamination, as in the implementation process of BA, all physicians, all inpatient and outpatient staff as well as managers need to be informed and undergo basic education regarding the intervention. As BA addresses a prevalent and frustrating issue in psychiatric health care, there is considerable risk that the approach leaks to the control group, reducing the possibility to detect between-group differences. In the current study this will be addressed through a register-based approach, comparing similar clinics, implementing BA at different timepoints over time. Individuals with traits of borderline personality disorder will be included and comparisons will be made with respect to compulsory care, voluntary inpatient care and mortality.

Interventions

OTHERBrief Admission by self-referral (BA)

Through means of an individualised contract access to self-referral to inpatient treatment limited to a maximum of three nights, three times per month.

Sponsors

Region Skane
Lead SponsorOTHER
Lund University
CollaboratorOTHER
Linkoeping University
CollaboratorOTHER_GOV

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Living in the uptake area of Lund, Linköping, Helsingborg or Norrköping * Age 18-65 years at the time of inclusion * Admitted to hospital either diagnosed with ICD-10 diagnosis BPD F60.3, or admitted at least twice with Intentional self-harm X60-83 in combination with one of more of the following diagnoses ADHD (F90.0-F90.X), Bipolar disorder type 2, (F31.8W, F318A-F, F31.0, F31.8-9, F31.8W) or Autism, Atypical autism, Aspergers syndrome (F84.0, F84.1, F84.5) or Mild intellectual disability (F70.0-F70.9).

Exclusion criteria

* not fulfilling inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Days with compulsory admission2010-09-15 - 2025-09-14Days with compulsory admission (days/year)

Secondary

MeasureTime frameDescription
Days with voluntary psychiatric admission2010-09-15 - 2025-09-14Days with voluntary psychiatric admission (days/year)
Duration of free intervals between admissions2010-09-15 - 2025-09-14Duration of free intervals between admissions (days)
Mortality2010-09-15 - 2025-09-14All cause mortality as well as death by suicide specifically (X60-X84 and Y10-Y34 in ICD10)
Number of compulsory admissions2010-09-15 - 2025-09-14Number of compulsory admissions (admissions/year)
Number of voluntary psychiatric admissions (admissions/year)2010-09-15 - 2025-09-14Number of voluntary psychiatric admissions
Number of compulsory acts/year2010-09-15 - 2025-09-14Number of compulsory acts/year

Countries

Sweden

Contacts

PRINCIPAL_INVESTIGATORSofie Sofie, PhD

Lund University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026